MedTrace Logo

Pilot Study of Biomarkers for Radiation Therapy

NCT01050725 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-06-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether specific assays of DNA damage repair proteins can be used in patients undergoing radiation therapy. The ultimate goal of this research is to develop clinically useful biomarkers from blood samples that could be used to customize radiation treatment for individuals, leading to reduced side effects and improved outcomes.

Conditions

Sponsors & Collaborators

  • Virginia Mason Hospital/Medical Center

    collaborator OTHER

  • Fred Hutchinson Cancer Center

    collaborator OTHER

  • Benaroya Research Institute

    lead OTHER

Principal Investigators

  • Kas R Badiozamani, MD · Virginia Mason Hospital/Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01050725 on ClinicalTrials.gov